Usefulness of fibroblast growth factor 23 and soluble suppression of tumorigenicity 2 as predictors of poor outcome in heart failure with preserved ejection fraction
26 August 2018 (09:24 - 09:33)
Organised by:
About the speaker
Jolimont Lobbes Hospital, La Louviere (Belgium)
9 More presentations in this session
Associate Professor K. Satoh (Sendai, JP)
Doctor M. Marcinkiewicz-Siemion (Bialystok, PL)
Doctor G. Savarese (Stockholm, SE)
Access the full session
The Event
ESC Congress 2018
26 August 2018
09:24 CET
You may be interested in
Congress Session
Congress Presentation
Congress Presentation
